Skip to main content
PACS logo

PACS · PACS Group, Inc. · Financials

Track PACS — free
$48.92 +0.60 (+1.23%) Play latest call Q3 2026 earnings call transcript
Market Cap
$7.67B
Shares
158.72M
Volume · Nov 16 109.49K Avg daily vol (3M) 791.32K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$5.29B +29.3%
FY2025 Revenue FY2022–FY2025
Net Income
$191.54M +243.5%
FY2025 Net Income FY2022–FY2025
Operating Margin
5.85% +2.8pp
FY2025 Operating Margin FY2022–FY2025
Diluted EPS
$1.22 +221.1%
FY2025 Diluted EPS FY2022–FY2025
Operating Cash Flow
$404.22M +10%
FY2025 Operating Cash Flow FY2022–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022
$5.75B – $5.85B $5.71B $5.29BG $4.09BG $3.11B $2.42B
— $1.74M $1.05M $3.08M $1M $1.36M
— $478.52M $415.07M $343.81M $213.66M $149.01M
— $5.28B $4.98B $3.97B $2.9B $2.19B
— $423.77M $309.6M $123.07M $207.77M $229.36M
— — 5.85% 3.01% 6.68% 9.47%
— $26.14M $28.36M $44.34M $49.92M $25.54M
— -$26.08M -$25.15M -$21.52M -$50.46M -$22.32M
— $1.54M -$773K -$4.57M -$391K -$346K
— $397.7M $284.45M $101.55M $157.32M $207.05M
— $120.09M $92.99M $46.21M $44.44M $56.55M
— $277.59M $191.54M $55.76M $112.87M $150.5M
— — 3.62% 1.36% 3.63% 6.21%
— $29K -$82K -$416K $8000 $0
USD/shares — $1.76 $1.23 $0.38 $0.88 $1.17
USD/shares — $1.76 $1.22 $0.38 $0.88 $1.17
shares — — 156.18M 146.66M 128.72M 128.72M
shares — — 156.7M 148.57M 128.72M 128.72M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $174.4M in dividends.

Debt Profile

Completed filing coverage through Aug 15, 2025

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current portion of long-term debt 2026-09-30 USD 7,984,000 10-Q filed 2026-11-03
Finance lease liabilities 2026-09-30 USD 61,238,000 10-Q filed 2026-11-03
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current finance lease liabilities
USD 27,090,000
Noncurrent finance lease liabilities
USD 34,148,000
Noncurrent line of credit borrowings 2026-09-30 USD 0 10-Q filed 2026-11-03
Noncurrent debt carrying amount 2026-09-30 USD 264,350,000 10-Q filed 2026-11-03
Operating lease liabilities 2026-09-30 USD 3,107,952,000 10-Q filed 2026-11-03
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 174,884,000
Noncurrent operating lease liabilities
USD 2,933,068,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
1.37×
Peer median 1.50×
EV/EBIT
18.47×
Peer median 18.13×
P/E (TTM common income)
27.63×
Peer median 22.03×
Price/Sales (TTM)
1.34×
Peer median 1.08×
Price/Book
6.32×
Peer median 3.16×
EV/Adj. EBITDA (FY2025)
15.50×
Peer median 12.39×

Peer medians compare against the 30 similar-size Medical Care Facilities companies (of 59 listed).

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022
Reportable Segment $5,288,932,000 $4,089,734,000 $3,111,492,000 $2,421,994,000
Key facts CIK 2001184 CUSIP 69380Q107 13F (30d) 191 filings 175 filers Visit website Investor relations